Akero Therapeutics Inc.

42.66
-0.92 (-2.11%)
At close: Mar 28, 2025, 3:59 PM
42.53
-0.30%
After-hours: Mar 28, 2025, 07:55 PM EDT

Akero Therapeutics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -7.41 -8.09 -19.62 -7.31 -10.25 -7.65 -4.76 -114.62
PEG Ratio -0.25 -2.26 5.67 -0.5 0.78 0.31 -0.00 n/a
PS Ratio n/a n/a n/a n/a n/a n/a n/a n/a
PB Ratio 2.49 2.29 6.54 4.36 3.14 2.60 -7.79 -114.62
P/FCF Ratio -8.12 -8.44 -23.09 -9.24 -11.44 -9.39 -40.4 -119.38
P/OCF Ratio -8.12 -8.44 -23.09 -9.24 -11.46 -9.39 -84.07 -119.38
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.00 0.05 0.03 0.01 0.01 n/a n/a n/a
Quick Ratio 19.38 29.27 18.61 7.70 20.70 14.73 32.93 2.87
Current Ratio 19.38 29.27 18.61 7.70 20.70 14.73 32.93 2.87
Asset Turnover n/a n/a n/a n/a n/a n/a n/a n/a
Interest Coverage 61.14 -55.78 -155.83 n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.34 -0.28 -0.33 -0.6 -0.31 -0.34 1.64 1.00
Return on Assets (ROA) -0.31 -0.26 -0.31 -0.52 -0.29 -0.32 -1.06 -6.94
Return on Capital (ROIC) -0.36 -0.31 -0.34 -0.59 -0.31 -0.35 -0.18 -10.47
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a n/a